Tobacco Smoking During Pregnancy: Detailed Risks to Embryo and Fetus by Developmental Stage
Cigarette smoke delivers nicotine, carbon monoxide, and over 7,000 chemicals directly to the fetal compartment. This article details the mechanisms and outcomes by developmental stage.
Pre-Implantation / Early Embryonic (Weeks 1–3)
- Reduced oocyte quality due to oxidative stress and mitochondrial dysfunction
- Lower fertilization rates; abnormal embryo cleavage
- Impaired blastocyst development; delayed hatching
- Increased implantation failure (altered endometrial receptivity)
Organogenesis (Weeks 4–10)
- Neural tube: Carbon monoxide–induced hypoxia and folate antagonism increase neural tube defect risk
- Cardiac: Disrupted neural crest migration leads to conotruncal defects
- Orofacial: Impaired palatal shelf fusion raises cleft lip/palate risk
- Limb: Vascular disruption causes reduction defects
- Gastrointestinal: Gastroschisis (vascular disruption theory)
Fetal Period (Week 11+)
- Growth restriction: Asymmetric intrauterine growth restriction (IUGR) with head-sparing; reduced placental weight and surface area
- Preterm birth: Inflammation triggers matrix metalloproteinase activation, weakening membranes; placental abruption risk increases
- Neurodevelopment: Reduced brain volume (corpus callosum, cerebellum); altered white matter; dopamine receptor changes
- Respiratory: Impaired alveolarization and surfactant production; increased airway reactivity
- Metabolic programming: "Thrifty phenotype" predisposes to obesity and insulin resistance later in life
Placental Pathology
- Infarcts, calcification, villous hypoplasia, fibrin deposition
- Reduced vascularization (increased anti-angiogenic factors)
- Abruption risk 1.5–2.5× higher (shear stress from vasoconstriction)
Fertility and Intergenerational Effects
- Female: Reduced ovarian reserve, earlier menopause
- Male: Lower sperm count, motility, increased DNA fragmentation
- Grandchildren: Epigenetic inheritance (animal data); increased asthma, obesity risk
Dose-Response and Cessation Benefits
- No safe threshold; linear dose-response for most outcomes
- Quit before 15 weeks: low birth weight and preterm risk approach non-smoker levels
- Quit 16–30 weeks: partial benefit
- Reduce by 50%: measurable birth weight gain
Provider-delivered cessation intervention is a core prenatal quality metric.
Pregnancy & Health - Related Articles
- Travel During High-Risk Pregnancy: Safety Guidelines & Precautions
- Pregnancy Nausea Relief: 18 Practical Tips for an Upset Stomach
- Pregnancy and Illness: Safe Self-Care and Red Flags for Medical Attention
- When to Schedule Your First Prenatal Appointment: Timing, What to Expect & Why Early Matters
- Bleeding & Cramping at 6 Weeks Pregnant (Normal Ultrasound): Causes & Next Steps
- Gestational Age Discrepancy: Ultrasound vs. Clinical Dating—Causes and Next Steps
- Chemotherapy & Pregnancy: Risks and Chances for a Healthy Baby
